Ashley Baldwin - Concepedia

Author

Ashley Baldwin

King's College London ORCID

Also Known As

A. Baldwin, A. Louise Baldwin, Ashley Baldwin, Ashley E. Baldwin

Publications

3.5K

Citations

H-Index

Concepts

All Affiliations

King's College London University of Cambridge University of Leicester University of Oxford MRC Biostatistics Unit

About

Ashley Baldwin is an author at King's College London specializing in medicine, covid-19, and antibiotics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	1.1K
2	Hospital Medicine	1	1	555
3	Neurology	1	1	160
4	Psychiatry	1	1	160
5	Alzheimer's Disease	1	1	160

Ashley Baldwin

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease Robert Howard, Rupert McShane, James Lindesay, New England Journal of Medicine	2012	751
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi, The Lancet Long CovidAntimicrobial StewardshipAntibioticsClinical InfectionPlatform Trial	2021	555
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2021	516
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet Covid-19 PandemicAntiviral TherapyClinical TrialsPlatform TrialMedicine	2022	382
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2021	289
Determining the minimum clinically important differences for outcomes in the DOMINO trial Robert Howard, Patrick Phillips, Tony Johnson, International Journal of Geriatric Psychiatry	2010	169
Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses Robert Howard, Rupert McShane, James Lindesay, The Lancet Neurology Neurodegenerative DiseasesNeuropsychologyAlzheimer's DiseaseSevere AlzheimerPsychiatry	2015	160
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2023	126
Cost‐effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO‐AD trial) Martín Knapp, Derek King, Renée Romeo, International Journal of Geriatric Psychiatry	2016	61
DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease – a multicentre RCT Rob Jones, Bart Sheehan, Patrick Phillips, Trials	2009	54

Page 1